Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11461)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 21, 2016 (publication date) through Feb 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ghosn M, Tabchi S, Kourie HR, Tehfe M. Metastatic gastric cancer treatment: Second line and beyond. World J Gastroenterol 2016; 22(11): 3069-3077 [PMID: 27003986 DOI: 10.3748/wjg.v22.i11.3069] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i11/3069.htm |
| Number | Citing Articles |
| 1 |
Jane E. Rogers, Lianchun Xiao, Allison Trail, Mariela Blum Murphy, Melissa Palmer, Jaffer A. Ajani. Nivolumab in Combination with Irinotecan and 5-Fluorouracil (FOLFIRI) for Refractory Advanced Gastroesophageal Cancer. Oncology 2020; 98(5): 289 doi: 10.1159/000505974
|
| 2 |
Emir Celik, Veysel Suzan, Nilay Sengul Samanci, Aysegul Akkan Suzan, Mehmet Karadag, Serdar Sahin, Muhammed Samil Aslan, Hakan Yavuzer, Nebi Serkan Demirci, Alper Doventas, Fuat Hulusi Demirelli. Sarcopenia assessment by new EWGSOP2 criteria for predicting chemotherapy dose-limiting toxicity in patients with gastrointestinal tract tumors. European Geriatric Medicine 2022; 13(1): 267 doi: 10.1007/s41999-021-00592-3
|
| 3 |
Ting Lu, Liang Sun, Xinguo Zhu. Yes-associated protein enhances proliferation and attenuates sensitivity to cisplatin in human gastric cancer cells. Biomedicine & Pharmacotherapy 2018; 105: 1269 doi: 10.1016/j.biopha.2018.06.031
|
| 4 |
Maria Bonomi, Daniele Spada, Gian Luca Baiocchi, Andrea Celotti, Matteo Brighenti, Giulia Grizzi. Targeting HER2 in Gastroesophageal Adenocarcinoma: Molecular Features and Updates in Clinical Practice. International Journal of Molecular Sciences 2024; 25(7): 3876 doi: 10.3390/ijms25073876
|
| 5 |
Anna Pous, Lucía Notario, Cinta Hierro, Laura Layos, Cristina Bugés. HER2-Positive Gastric Cancer: The Role of Immunotherapy and Novel Therapeutic Strategies. International Journal of Molecular Sciences 2023; 24(14): 11403 doi: 10.3390/ijms241411403
|
| 6 |
Matheus Sewastjanow-Silva, Kohei Yamashita, Ernesto Rosa Vicentini, Meita Hirschmann, Melissa Pool Pizzi, Allison Michelle Trail, Rebecca E Waters, Jane E. Rogers, Jaffer A Ajani. Nivolumab with or without chemotherapy for metastatic gastroesophageal cancers and future perspectives. Expert Review of Anticancer Therapy 2022; 22(11): 1177 doi: 10.1080/14737140.2022.2139241
|
| 7 |
Mustapha Tehfe, Samer Tabchi, Maria Maddalena Laterza, Ferdinando De Vita. Ramucirumab in Her-2-Positive Gastroesophageal Adenocarcinoma: An Argument for Overcoming Trastuzumab Resistance. Future Oncology 2018; 14(3): 223 doi: 10.2217/fon-2017-0434
|
| 8 |
Niranjan Awasthi, Margaret A. Schwarz, Changhua Zhang, Stephan G. Klinz, Florence Meyer-Losic, Benjamin Beaufils, Arunthathi Thiagalingam, Roderich E. Schwarz. Augmenting Experimental Gastric Cancer Activity of Irinotecan through Liposomal Formulation and Antiangiogenic Combination Therapy. Molecular Cancer Therapeutics 2022; 21(7): 1149 doi: 10.1158/1535-7163.MCT-21-0860
|
| 9 |
Ran Chen, Qi‑Tian Chen, You‑Hong Dong. Clinical efficacy of apatinib in treating metastatic gastric cancer and its effect on IL‑17. Oncology Letters 2019; doi: 10.3892/ol.2019.10270
|
| 10 |
Guannan Wang, Xu Wang, Meng Han, Xiaoming Wang. Loss of DAB2IP Contributes to Cell Proliferation and Cisplatin Resistance in Gastric Cancer. OncoTargets and Therapy 2021; : 979 doi: 10.2147/OTT.S289722
|
| 11 |
Khalil El Gharib, Hampig Raphael Kourie. Is Ramucirumab Still the Only Second-Line Treatment in Metastatic Gastric Cancer?. Pharmacogenomics 2020; 21(17): 1203 doi: 10.2217/pgs-2020-0118
|
| 12 |
Shuqin Jia, Tingting Qu, Xiaohong Wang, Mengmeng Feng, Yang Yang, Xuemin Feng, Ruiting Ma, Wenmei Li, Ying Hu, Yi Feng, Ke Ji, Ziyu Li, Wenguo Jiang, Jiafu Ji, Aamir Ahmad. KIAA1199 promotes migration and invasion by Wnt/β-catenin pathway and MMPs mediated EMT progression and serves as a poor prognosis marker in gastric cancer. PLOS ONE 2017; 12(4): e0175058 doi: 10.1371/journal.pone.0175058
|
| 13 |
Yimeng Ma, Jingjing Jin, Zixuan Xue, Jungang Zhao, Weiyang Cai, Wanli Zhang. Integrated multi-omics analysis and machine learning developed a prognostic model based on mitochondrial function in a large multicenter cohort for Gastric Cancer. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05109-7
|
| 14 |
Pranav Abraham, Liya Wang, Zhengzheng Jiang, Joseph Gricar, Hiangkiat Tan, Ronan J Kelly. Healthcare Utilization and Total Costs of Care Among Patients with Advanced Metastatic Gastric and Esophageal Cancer. Future Oncology 2021; 17(3): 291 doi: 10.2217/fon-2020-0516
|
| 15 |
Seong Kyeong Lim, Kyoungwon Jung, Moo In Park, Jae Hyun Kim, Sung Eun Kim, Won Moon, Seun Ja Park. Factors Affecting Long Term Survival for Metastatic Gastric Cancer Treated with Chemotherapy. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2016; 16(2): 97 doi: 10.7704/kjhugr.2016.16.2.97
|
| 16 |
So-Woon Kim, Gowun Jeong, Min-Hee Ryu, Young Soo Park. Comparison of PD-L1 immunohistochemical assays in advanced gastric adenocarcinomas using endoscopic biopsy and paired resected specimens. Pathology 2021; 53(5): 586 doi: 10.1016/j.pathol.2020.10.015
|
| 17 |
Niranjan Awasthi, Margaret A. Schwarz, Quinn Kaurich, Changhua Zhang, Frank Hilberg, Roderich E. Schwarz. Enhancing gastric cancer conventional chemotherapy effects by triple angiokinase inhibitor nintedanib in preclinical models. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1145999
|
| 18 |
Tomokazu Tanaka, Jun Nakamura, Hirokazu Noshiro. Promising immunotherapies for esophageal cancer. Expert Opinion on Biological Therapy 2017; 17(6): 723 doi: 10.1080/14712598.2017.1315404
|
| 19 |
G. Ku, G.M. Haag, H. Park, V.K. Lam, T.J. George, S.S. Kim, M. Gutierrez, V. Shankaran, S. Stein, C.S. Denlinger, E. Elimova, A. Nagrial, A.R. He, M.B. Sawyer, H.H. Yoon, R. Geva, J. Starr, G. Curigliano, T. Golan, R. von Moos, R. Fritsch, D. Lim, Q. Wang, A. Patel, T. Aoyama, M. Lei, D. Greenawalt, M. Di Bartolomeo. Nivolumab combination therapies in patients with advanced gastric and gastroesophageal junction cancer: the phase II FRACTION gastric cancer study. ESMO Open 2025; 10(2): 104107 doi: 10.1016/j.esmoop.2024.104107
|
| 20 |
Julien Taieb, Markus Moehler, Narikazu Boku, Jaffer A. Ajani, Eduardo Yañez Ruiz, Min-Hee Ryu, Silke Guenther, Vikram Chand, Yung-Jue Bang. Evolution of checkpoint inhibitors for the treatment of metastatic gastric cancers: Current status and future perspectives. Cancer Treatment Reviews 2018; 66: 104 doi: 10.1016/j.ctrv.2018.04.004
|
| 21 |
Tao Chen, Dongbao Li, Yunliang Wang, Xiaochun Shen, Anqi Dong, Chao Dong, Kaipeng Duan, Jiayu Ren, Weikang Li, Gege Shu, Jiaoyang Yang, Yufeng Xie, Fuliang Qian, Jin Zhou. Loss of NDUFS1 promotes gastric cancer progression by activating the mitochondrial ROS-HIF1α-FBLN5 signaling pathway. British Journal of Cancer 2023; 129(8): 1261 doi: 10.1038/s41416-023-02409-5
|
| 22 |
Ronan J. Kelly, Jeeyun Lee, Yung-Jue Bang, Khaldoun Almhanna, Mariela Blum-Murphy, Daniel V.T. Catenacci, Hyun Cheol Chung, Zev A. Wainberg, Michael K. Gibson, Keun-Wook Lee, Johanna C. Bendell, Crystal S. Denlinger, Cheng Ean Chee, Takeshi Omori, Rom Leidner, Heinz-Josef Lenz, Yee Chao, Marlon C. Rebelatto, Philip Z. Brohawn, Peng He, Jennifer McDevitt, Siddharth Sheth, Judson M. Englert, Geoffrey Y. Ku. Safety and Efficacy of Durvalumab and Tremelimumab Alone or in Combination in Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma. Clinical Cancer Research 2020; 26(4): 846 doi: 10.1158/1078-0432.CCR-19-2443
|
| 23 |
Haoran Li, Zhengwu Cheng, Bin Jiang, Xinyu Shao, Menglin Xu. Prognosis value and positive association of Rab1A/IL4Rα aberrant expression in gastric cancer. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-33955-w
|
| 24 |
Sara Peri, Alessio Biagioni, Giampaolo Versienti, Elena Andreucci, Fabio Staderini, Giuseppe Barbato, Lisa Giovannelli, Francesco Coratti, Nicola Schiavone, Fabio Cianchi, Laura Papucci, Lucia Magnelli. Enhanced Vasculogenic Capacity Induced by 5-Fluorouracil Chemoresistance in a Gastric Cancer Cell Line. International Journal of Molecular Sciences 2021; 22(14): 7698 doi: 10.3390/ijms22147698
|
| 25 |
Wojciech Marlicz, Katarzyna Sielatycka, Karol Serwin, Ewa Kubis, Marta Tkacz, Rafał Głuszko, Andrzej Białek, Teresa Starzyńska, Mariusz Z. Ratajczak. Effect of colorectal cancer on the number of normal stem cells circulating in peripheral blood. Oncology Reports 2016; 36(6): 3635 doi: 10.3892/or.2016.5179
|
| 26 |
Md Sazzad Hassan, Niranjan Awasthi, Saisantosh Ponna, Urs von Holzen. Nab-Paclitaxel in the Treatment of Gastrointestinal Cancers—Improvements in Clinical Efficacy and Safety. Biomedicines 2023; 11(7): 2000 doi: 10.3390/biomedicines11072000
|
| 27 |
Therese Triemer, Alessandra Messikommer, Stella M. K. Glasauer, Jawad Alzeer, Miriam H. Paulisch, Nathan W. Luedtke. Superresolution imaging of individual replication forks reveals unexpected prodrug resistance mechanism. Proceedings of the National Academy of Sciences 2018; 115(7) doi: 10.1073/pnas.1714790115
|
| 28 |
Jia Wang, Zheng Sun, Shihai Yan, Feng Gao. Effect of miR‑145 on gastric cancer cells. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.10015
|